• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAlpha Tau Medical
    Picture of Alpha Tau Medical logo

    DRTS — Alpha Tau Medical News Story

    $13.160.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    • Market Cap
      $1.22bn
    • Enterprise Value
      $1.12bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • DRTS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    DRTS Dividends
    All News

    Brief: Alpha Tau Announces Resignation Of Gary Leibler From Its Board Of Directors

    Picture of Alpha Tau Medical logoAlpha Tau Medical
    07/06/2022 22:53
    Alpha Tau Medical Ltd  DRTS.O :
        * ALPHA TAU ANNOUNCES RESIGNATION OF GARY LEIBLER FROM ITS
    BOARD
    OF DIRECTORS
    
    Source text for Eikon:  ID:nPn10vl4ha 
    Further company coverage:  DRTS.O
    

    Recent news on Alpha Tau Medical

    See all news
    • Brief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee

      17/08/2026 13:34
    • Brief: Alpha Tau Completes Patient Enrollment In Its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal Of FDA Approval Of Alpha Dart® To Treat Recurrent Cutaneous Squamous Cell Carcinoma

      08/05/2026 14:01
    • Brief: Alpha Tau Announces 100% Local Disease Control Rate And Favorable Safety Profile Observed In Alpha Dart® Pancreatic Cancer Trials Presented At Ddw 2026

      04/05/2026 14:17
    • Brief: Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing

      28/04/2026 11:27
    • Brief: Alpha Tau Announces First-Ever Oral Presentation Of Alpha Dart® Pancreatic Cancer Data At Digestive Disease Week (Ddw) 2026

      31/03/2026 14:25

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.